Hypoxia modulates CCR7 expression in head and neck cancers

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Chemokine receptor CCR7 is crucial for immune cell trafficking to lymphoid organs.
• Elevated CCR7 expression is linked to lymph node metastasis in head and neck cancers.
• Factors inducing CCR7 in head and neck cancers remain largely unknown.

Purpose of the Study:

• To investigate the role of hypoxia in regulating CCR7 expression in head and neck cancer.
• To analyze the correlation between hypoxia and CCR7 in vitro, in vivo, and in clinical samples.

Main Methods:

• Assessed CCR7 protein expression and function under normoxia and hypoxia in multiple head and neck cancer cell lines (monolayers, spheroids) and xenografts.
• Examined CCR7 expression in 80 clinical head and neck tumor samples using tissue microarrays.
• Correlated CCR7 expression with the hypoxia marker HIF-1α in clinical samples.

Main Results:

• Hypoxia significantly increased CCR7 expression in both in vitro and in vivo head and neck cancer models.
• A positive correlation between HIF-1α and CCR7 expression was observed across all clinical stages of head and neck cancer.
• This correlation was particularly strong in early histological grades of tumors.

Conclusions:

• Hypoxia is a key regulator of CCR7 expression in head and neck cancers.
• The hypoxia-CCR7 axis may contribute to the metastatic potential of head and neck tumors.
• Targeting this pathway could offer new therapeutic strategies for head and neck cancer metastasis.